IRIS

Sfoglia per SSD  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 654 a 673 di 1.017
Data di pubblicazione Titolo Autore(i) Tipo File
5-nov-2019 Nonclinical data supporting orphan medicinal product designations in the area of rare infectious diseases Sheean, Me; Malikova, E; Duarte, D; Capovilla, G; Fregonese, L; Hofer, Mp; Magrelli, A; Mariz, S; Mendez-Hermida, F; Nistico, R; Leest, T; Sipsas, Nv; Tsigkos, S; Vitezic, D; Larsson, K; Sepodes, B; Stoyanova-Beninska, V Articolo su rivista
19-gen-2015 A not cytotoxic nickel concentration alters the expression of neuronal differentiation markers in NT2 cells Ceci, C; Barbaccia, Ml; Pistritto, G Articolo su rivista
1-gen-2010 Novel Glutathione S-Transferase Inhibitor Enhances Temozolomide Efficacy Against Malignant Melanoma 52nd Annual Meeting of the Italian Cancer Society. Lost in translation: bridging the gap between cancer research and effective therapies Tentori, L; Dorio, As; Mazzon, E; Muzi, A; Saua, A; Cuzzocrea, S; Federici, G; Caccuri, Am; Graziani, G Intervento a convegno
1-gen-2010 The novel proapoptotic activity of nonnatural enantiomer of Lentiginosine Macchi, B; Minutolo, A; Grelli, S; Cardona, F; Cordero, F; Mastino, A; Brandi, A Articolo su rivista
1-gen-2015 A novel water-soluble nitrobenzoxadiazole is highly effective against vemurafenib-resistant human melanoma cells DE LUCA, A; Graziani, G; Rotili, D; Muzi, A; Mai, A; Leonetti, C; Artuso, S; Bonanno, E; Tentori, L; Caccuri, Am Intervento a convegno
16-gen-2014 A novel, cell-free PCR-based assay for evaluating the inhibitory activity of antiretroviral compounds towards HIV reverse transcriptase Frezza, C; Balestrieri, E; Marino Merlo, F; Mastino, A; Macchi, B Articolo su rivista
1-set-2014 Nuovi antitumorali per la targeted therapy: pro e contro Graziani, G Contributo in libro
1-gen-2014 Nurses’ reporting of Spontaneous Adverse Drug Reactions (ADRs): Identifying the factors that hinder ADRs reporting and testing an explanatory model to predict nurses’ intention to report ADRs - Tesi di dottorato
1-gen-2008 Nutritional habits and body mass index in the elderly population: Can this information be useful before planning chemotherapy administration in older cancer patients? Monfardini, S; Basso, U; Sergi, G; Repetto, L; Santurri, P; Trabucchi, Mm Articolo su rivista
1-lug-2004 Nutritional intervention in special care units for dementia Boffelli, S; Rozzini, R; Trabucchi, Mm Articolo su rivista
15-dic-1995 O6-alkylguanine-DNA alkyltransferase attenuates triazene-induced cytotoxicity and tumor cell immunogenicity in murine L1210 leukemia Graziani, G; Faraoni, I; Grohmann, U; Bianchi, R; Binaglia, L; Margison, G; Watson, A; Orlando, L; Bonmassar, E; D'Atri, S Articolo su rivista
1-gen-1990 Omegaconotoxin binding decreases in aged rat brain Moresco, R; Govoni, S; Battaini, Fm; Trivulzio, S; Trabucchi, Mm Articolo su rivista
1-ago-2021 Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidence Hampel, H; Nistico', R; Seyfried, Nt; Levey, Ai; Modeste, E; Lemercier, P; Baldacci, F; Toschi, N; Garaci, F; Perry, G; Emanuele, E; Valenzuela, Pl; Lucia, A; Urbani, A; Sancesario, Gm; Mapstone, M; Corbo, M; Vergallo, A; Lista, S Articolo su rivista
1-gen-2019 On the Horizon: Targeting Next-Generation Immune Checkpoints for Cancer Treatment Tundo, Gr; Sbardella, D; Lacal, Pm; Graziani, G; Marini, S Articolo su rivista
1-mar-1983 On the mode of action of imipramine: relationship between serotonergic axon terminal function and down-regulation of beta-adrenergic receptors Barbaccia, Ml; Brunello, N; Chuang, D; Costa, E Articolo su rivista
1-gen-2019 Optimising bench science to withstand regulatory scrutiny Borg, J-; Melchiorri, D; Sepodes, B; Caramella, Cm; Tomino, C; Micallef, B; Serracino-Inglott, A; Nistico, R Articolo su rivista
1-gen-2005 Oral administration of PARP inhibitor GPI 18180 increases the anti-tumor activity of temozolomide against intracranial melanoma in mice. Lapidus, R; Tentori, L; Graziani, G; Leonetti, C; Scarsella, M; Vergati, M; Muzi, A; Zhang, J; and the Guilford PARP Project, G Intervento a convegno
1-gen-2006 Oral administration of poly(ADP-ribose) polymerase inhibitor prevents intestinal damage induced by irinotecan and enhances the efficacy of irinotecan and temozolomide combination against colon carcinoma. Zhang, J; Tentori, L; Leonetti, C; Scarsella, M; Muzi, A; Mazzon, E; Vergati, M; Forini, O; Lapidus, R; Xu, W; Cuzzocrea, S; Graziani, G Intervento a convegno
1-gen-2005 Oral administration of the PARP inhibitor GPI 15427 increases the activity of anticancer drugs with different mechanisms of action Vergati, M; Leonetti, C; Scarsella, M; Muzi, A; Forini, O; Xu, W; Zhang, J; Tentori, L; Graziani, G Intervento a convegno
1-gen-2005 Oral administration of the PARP-1 inhibitor GPI 15427 increases the anti-tumor activity of irinotecan against colon carcinomas Tentori, L; Leonetti, C; Scarsella, M; Vergati, M; Muzi, A; Xu, W; Lapidus, R; Zhang, J; Graziani, G Intervento a convegno
Mostrati risultati da 654 a 673 di 1.017
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile